Lupin Grants 40,157 Stock Options Under ESOP Scheme 2025
Lupin Ltd · Others (Uncategorized) · 20 Oct 2026, 12:33 am
Lupin Grants 40,157 Stock Options Under ESOP Scheme 2025 Lupin's Nomination and Remuneration Committee approved the grant of 40,157 stock options to eligible employees of the company and its subsidiaries on 19th Oct'26 under the Lupin Employees Stock Option Scheme 2025. Each option is convertible into one equity share at an exercise price of ₹2.00 per share. Vesting occurs in three equal annual tranches of one-third starting one year post-grant, subject to performance criteria, with a maximum exercise period of eight years from the grant date.
Original exchange filing (PDF)
More announcements from Lupin Ltd
- Lupin Announces European Launch of Biosimilar Ranibizumab. · 12 Nov 2026
- Transcript of Q2 FY2027 Earnings Conference Call. · 07 Nov 2026
- Link of Audio recording of the Earnings Call-Q2 FY27. · 05 Nov 2026
- Investor Presentation- Q2 FY2027 · 04 Nov 2026
- Lupin Q2 FY2027 Results · 04 Nov 2026
- Appointment of Mr. Akhil Gupta as an Additional Director (Non-Executive, Independent) effective November 03, 2026 and as an Independent Director for a term of five consecutive years with .... · 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. · 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. · 04 Nov 2026
